New targeted drug trial seeks to control advanced cancers with specific mutation
NCT ID NCT05307705
Summary
This early-stage study is testing a new drug called LOXO-783, both alone and combined with other cancer treatments. It is for adults with advanced breast cancer or other solid tumors that have a specific genetic change called a PIK3CA H1047R mutation. The main goals are to find a safe dose and see if the drug can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center Hospital
Nagoya, 464-8681, Japan
-
Asan Medical Center
Seoul, 5505, South Korea
-
BC Cancer Vancouver
Vancouver, V5Z4E6, Canada
-
Beijing Cancer hospital
Beijing, 100036, China
-
Cancer Research SA
Adelaide, 5000, Australia
-
Centre Leon Berard
Lyon, 69373, France
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
-
Gustave Roussy
Villejuif, 94805, France
-
Hospital Arnau de Vilanova Valencia
Valencia, 46015, Spain
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital General Universitario Gregorio Maranon
Madrid, 28007, Spain
-
Hospital Quironsalud Madrid
Pozuelo de Alarcón, 28223, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Quiron Dexeus
Barcelona, 08028, Spain
-
ICANS_Institut de Cancerologie Strasbourg Europe
Strasbourg, 67033, France
-
Institut Curie
Paris, 75248, France
-
Institut Jules Bordet
Anderlecht, 1070, Belgium
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
-
Kyoto University Hospital
Kyoto, 606-8507, Japan
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905-0002, United States
-
Mayo Clinic of Scottsdale
Scottsdale, Arizona, 85259, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Cancer Center Hospital
Chūōku, 104-0045, Japan
-
National Cancer Centre Singapore
Singapore, 169610, Singapore
-
Peter Maccallum Cancer Institute Erb
East Melbourne, 3002, Australia
-
Princess Margaret Hospital (Hong Kong)
Toronto, M5G 2M9, Canada
-
Royal Marsden Hospital (Sutton)
Sutton, SM2 5PT, United Kingdom
-
Royal Marsden NHS Trust
London, SW3 6JJ, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
South Texas Accelerated Research Therapeutics (START)
San Antonio, Texas, 78229, United States
-
St Vincent's Hospital
Sydney, 2010, Australia
-
Stanford University Hospital
Stanford, California, 94305, United States
-
Tennessee Oncology PLLC
Nashville, Tennessee, 37203, United States
-
Texas Oncology-Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
-
The Cancer Institute Hospital of JFCR
Kōtō City, 135-8550, Japan
-
The Third Hospital of Nanchang
Nanchang, 330009, China
-
UCLA Medical Center
Los Angeles, California, 90095, United States
-
UCSF Medical Center at Mission Bay
San Francisco, California, 94158, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390-8884, United States
-
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Washington University Medical School
St Louis, Missouri, 63110, United States
-
Wilmot Cancer Institute
Rochester, New York, 14642, United States
-
Winship Cancer Center Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.